ГЕНЕТИЧЕСКИЕ АСПЕКТЫ ПРОГНОЗИРОВАНИЯ ОСТЕОПОРОЗА У ЖЕНЩИН В ПЕРЕМЕНОПАУЗЕ (ОБЗОР ЛИТЕРАТУРЫ)

Altshuler, D., et al. (2016). Design and analysis of genetic association studies. Nature Reviews Genetics, 17(5), 275-289.

Black, D. M., & Rosen, C. J. (2016). Clinical practice. Postmenopausal osteoporosis. New England Journal of Medicine, 374(3), 254-262

Bush, W. S., & Moore, J. H. (2018). Genotyping technologies for genetic research. Annual Review of Genomics and Human Genetics, 19, 269-293.

Cordell, H. J., & Clayton, D. G. (2019). Statistical methods for genetic epidemiology. Genetic Epidemiology, 43(6), 613-628.

Compston, J. E., & McClung, M. R. (2018). Bone Health During the Menopause Transition and Beyond. Endocrine Reviews, 39(5), 687-709.

Duncan, E. L., & Brown, M. A. (2018). Genetic Determinants of Osteoporosis: Common Variants to Rare Mutations. Nature Reviews Endocrinology, 14(9), 509-522.

Eastell, R., & Szulc, P. (2017). Use of bone turnover markers in postmenopausal osteoporosis. Lancet Diabetes & Endocrinology, 5(11), 908-923.

Khera, A. V., et al. (2018). Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations. Nature Genetics, 50(9), 1219-1224.

Kemp, J. P., et al. (2020). Large-scale genome-wide association study of osteoporosis. Journal of Clinical Endocrinology & Metabolism, 105(8), 2563-2575.

Martin, A. R., et al. (2019). Clinical use of current polygenic risk scores may exacerbate health disparities. Nature Genetics, 51(4), 584-591.

Morris, J. A., et al. (2017). Identification of 153 new loci associated with heel bone mineral density and functional involvement of GPC6 in osteoporosis. Nature Genetics, 49(10), 1468-1475.

Liu, C. T., et al. (2021). Genetic risk scores for osteoporosis: a systematic review. Journal of Bone and Mineral Research, 36(3), 421-433.

Richards, J. B., et al. (2019). Genetic variants associated with bone mineral density in premenopausal and postmenopausal women. Bone, 123, 45-53.

Sirugo, G., et al. (2019). The missing diversity in human genetic studies. Cell, 177(1), 26-31.

Torkamani, A., et al. (2018). The personal and clinical utility of polygenic risk scores. Nature Reviews Genetics, 19(9), 581-590.

Wray, N. R., et al. (2018). Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression. Nature Genetics, 50(5), 668-681.